Meeting
2014 ASCO Annual Meeting
Treatment outcomes and prognostic factors for primary mediastinal B-cell lymphoma: The MD Anderson experience.
Authors
Mohamed Amin Ahmed
Department of Lymphoma and Myeloma, The University of Texas MD Anderson Cancer Center, Houston, TX
Mohamed Amin Ahmed , Ramona Barac , L Jeffrey Medeiros , Long Ma , Luis Fayad , Jorge Enrique Romaguera , Yasuhiro Oki , M.Alma Rodriguez , Chelsea Pinnix , Larry W. Kwak , Fredrick B. Hagemeister Jr., Richard Eric Davis , Jason R. Westin
Disclaimer
This material on this page is ©2024 American Society of Clinical Oncology, all rights reserved. Licensing available upon request. For more information, please contact licensing@asco.org
Poster Details
Session Type
Poster Session
Session Title
Lymphoma and Plasma Cell Disorders
Track
Hematologic Malignancies—Lymphoma and Chronic Lymphocytic Leukemia
Sub Track
Lymphoma
Citation
J Clin Oncol 32:5s, 2014 (suppl; abstr 8564)
DOI
10.1200/jco.2014.32.15_suppl.8564
Abstract #
8564
Poster Bd #
251
Abstract Disclosures
Similar Posters
Poster
2020 ASCO Virtual Scientific Program
Role of radiotherapy and dose-densification of R-CHOP in primary mediastinal B-cell lymphoma: A subgroup analysis of the unfolder trial of the German Lymphoma Alliance (GLA).
First Author: Gerhard Held
Poster
2015 ASCO Annual Meeting
Role of radiation (RT) in primary mediastinal large B-cell lymphoma (PMBCL): An analysis of the Surveillance, Epidemiology, and End Results (SEER) database.
First Author: Smith Giri
Poster
2014 ASCO Annual Meeting
Treatment of HIV-associated plasmablastic lymphoma: A single-center experience with 25 patients.
First Author: Ibrahim Fuad Ibrahim
Poster
2020 ASCO Virtual Scientific Program
Clinicopathologic features and outcomes of de novo transformed indolent lymphoma.
First Author: Collin K Chin